CPT code 92961 designates a combined therapeutic intervention for patients with acute arrhythmia, pairing synchronized electrical cardioversion with intravenous antiarrhythmic medication. This procedure is clinically significant because it addresses life‑threatening cardiac rhythm disturbances and typically occurs in monitored emergency or inpatient settings, making coding and coverage decisions consequential for acute-care billing and hospital workflows. Key national payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what CPT code 92961 represents, the clinical context for its use, and how it fits into service lines for emergency and inpatient cardiac care. The publication summarizes payer coverage considerations, common modifiers, and relevant service-level benchmarks where available. It also outlines policy and billing issues that frequently arise with acute cardioversion combined with IV drug therapy, such as documentation of medical necessity, facility versus professional components, and appropriate place-of-service coding. Data not provided in the input—such as specific payer rates, ICD‑10 pairings, and taxonomy mappings—is noted as not available where applicable.